APA (7th ed.) Citation

PR, F., A, G., AM, V., G, B., R, G., N, P., . . . E, B. (1998). A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes. British journal of haematology, 103(4), 1070. https://doi.org/10.1046/j.1365-2141.1998.01085.x

Chicago Style (17th ed.) Citation

PR, Ferrini, Grossi A, Vannucchi AM, Barosi G, Guarnone R, Piva N, Musto P, and Balleari E. "A Randomized Double-blind Placebo-controlled Study with Subcutaneous Recombinant Human Erythropoietin in Patients with Low-risk Myelodysplastic Syndromes." British Journal of Haematology 103, no. 4 (1998): 1070. https://doi.org/10.1046/j.1365-2141.1998.01085.x.

MLA (9th ed.) Citation

PR, Ferrini, et al. "A Randomized Double-blind Placebo-controlled Study with Subcutaneous Recombinant Human Erythropoietin in Patients with Low-risk Myelodysplastic Syndromes." British Journal of Haematology, vol. 103, no. 4, 1998, p. 1070, https://doi.org/10.1046/j.1365-2141.1998.01085.x.